CALCULATE YOUR SIP RETURNS

Stocks To Watch Today on December 27, 2024: Gensol, Dixon, Mankind, Jubilant and More Can be in Focus

27 December 20243 mins read by Angel One
Indian markets are likely to be impacted, as indicated by GIFT Nifty Futures. Key stocks: Gensol's ₹897 crore deal, Dixon's MoU, Mankind's partnership, Jubilant's tie-up with Coca-Cola.
Stocks To Watch Today on December 27, 2024: Gensol, Dixon, Mankind, Jubilant and More Can be in Focus
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

On December 27, Indian equities might be impacted today, as indicated by GIFT Nifty futures, which were trading 4 points lower at 23,952. 

On Thursday, the BSE Sensex closed flat at 78,472.48, while the Nifty50 rose by 22 points or 0.10% to end at 23,750.20.

Here are some key stocks to keep an eye on:

  • Gensol Engineering

Gensol Engineering secured a ₹897 crore EPC contract from NTPC Renewable Energy for 225 MW solar PV projects at GSECL Solar Park, Gujarat.

  • Dixon Technologies

Dixon Technologies subsidiary Dixon Electro Manufacturing signed an MoU with Cellecor Gadgets to manufacture refrigerators and components.

  • Mankind Pharma

Mankind Pharma partnered with Innovent Biologics to exclusively license and commercialise the cancer immunotherapy drug Sintilimab in India.

  • Jubilant FoodWorks

Jubilant FoodWorks signed an MoU with Coca-Cola India to procure sparkling beverages and other offerings.

  • Gujarat Fluorochemicals

Gujarat Fluorochemicals approved a ₹200 crore slump sale of its power undertaking, a ₹40 crore investment in IGREL Mahidad, and a ₹200 crore investment for a 26% stake in Flurry Wind Energy.

  • Aarti Pharmalabs

Abakkus Asset Manager bought 10.7 lakh shares worth ₹61.5 crore at ₹575.04/share. Promoters sold 10 lakh shares.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

 

Investments in securities market are subject to market risks, read all the related documents carefully before investing.

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Send App Link
Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2 Cr+ happy customers